Accessibility Menu
 
Rubicon Organics logo

Rubicon Organics

(OTC) ROMJF

Current Price$0.36
Market Cap$23.98M
Since IPO (2018)-78%
5 Year-87%
1 Year+1%
1 Month-7%

Rubicon Organics Financials at a Glance

Market Cap

$23.98M

Revenue (TTM)

$59.44M

Net Income (TTM)

$1.05M

EPS (TTM)

$0.01

P/E Ratio

31.32

Dividend

$0.00

Beta (Volatility)

0.39 (Low)

Price

$0.36

Volume

62

Open

$0.36

Previous Close

$0.36

Daily Range

$0.36 - $0.36

52-Week Range

$0.28 - $0.54

ROMJF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rubicon Organics

Industry

Pharmaceuticals

Employees

210

CEO

Margaret Brodie, CPA

Headquarters

Vancouver, BC V6C 1A5, CA

ROMJF Financials

Key Financial Metrics (TTM)

Gross Margin

26%

Operating Margin

-3%

Net Income Margin

2%

Return on Equity

3%

Return on Capital

-3%

Return on Assets

2%

Earnings Yield

3.19%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$23.98M

Shares Outstanding

67.18M

Volume

62

Short Interest

0.00%

Avg. Volume

20.78K

Financials (TTM)

Gross Profit

$6.79M

Operating Income

$15.32M

EBITDA

$11.96M

Operating Cash Flow

$3.62M

Capital Expenditure

$8.41M

Free Cash Flow

$12.03M

Cash & ST Invst.

$3.99M

Total Debt

$12.41M

Rubicon Organics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$16.45M

+15.8%

Gross Profit

$2.93M

-157.1%

Gross Margin

-17.83%

N/A

Market Cap

$23.98M

N/A

Market Cap/Employee

$115.30K

N/A

Employees

208

N/A

Net Income

$2.23M

-4597.1%

EBITDA

$4.63M

-520.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$8.43M

-26378.8%

Accounts Receivable

$9.29M

+59.4%

Inventory

$19.47M

+54.9%

Long Term Debt

$10.64M

+25.2%

Short Term Debt

$1.82M

+31.4%

Return on Assets

1.57%

N/A

Return on Invested Capital

-3.16%

N/A

Free Cash Flow

$5.38M

-393.4%

Operating Cash Flow

$3.44M

-251.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GBLPGlobal Pharmatech, Inc.
$0.05+0.00%
MEDIFMediPharm Labs Corp.
$0.05-3.81%
HSTIHigh Sierra Technologies, Inc.
$1.40+0.00%
CNTMFFluent Corp.
$0.03+3.03%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$128.06-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$49.17+0.00%

Questions About ROMJF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.